PATH (UiPath NYSE) $11.06 intraday 19 Feb 2026: AI demand and earnings test

UiPath Inc. (PATH) shares trade at $11.06 on the NYSE intraday on 19 Feb 2026, making the stock a near-term focus for AI investors. PATH stock is down about 30.07% YTD, yet trades above its 52-week low of $9.38. Investors watch the March 11, 2026 earnings date and AI adoption in automation. Volume sits at 4,060,867 versus a 30-day average near 32,225,067, showing lighter intraday liquidity. We assess fundamentals, technicals, analyst targets and Meyka AI model forecasts for a clear PATH stock outlook.

PATH stock intraday snapshot

UiPath Inc. (PATH) trades at $11.06 on the NYSE in the United States. The stock opened at $11.10, with a day low of $10.93 and a day high of $11.19. Market cap is $5.94 billion and shares outstanding are 534,679,152. Trading volume of 4,060,867 is below the average volume of 32,225,067, signaling lighter intraday participation.

PATH stock drivers: earnings and AI demand

PATH stock will react to the earnings release slated for 11 March 2026, with consensus EPS expectations near $0.25 and revenue around $464.86 million per recent research. Analyst revisions ahead of that report will move sentiment quickly. Enterprise demand for RPA plus embedded AI remains the primary growth engine for UiPath, especially in banking and healthcare.

PATH stock valuation and key financial metrics

UiPath shows a trailing EPS of $0.42 and a PE of 26.44 on the current price. Price-to-sales stands at 3.90 and price-to-book at 3.17. Cash per share is $2.59 and the current ratio is 2.54, showing balance-sheet strength. Revenue-per-share is $2.88 and free cash flow per share is $0.58, supporting a valuation that looks mid-growth for the Software – Infrastructure industry.

PATH stock technicals and trading setup

Short-term indicators show PATH stock is oversold: RSI 31.23 and Stochastic %K 9.83. The 50-day average is $15.38 and the 200-day average is $13.55, both above the current price. Bollinger lower band sits near $10.28, giving technical support in the low $10 range. Traders should watch relative volume and the ATR 0.80 for intraday risk control.

Meyka AI rates PATH with a score out of 100 and forecast

Meyka AI rates PATH with a score of 75.83 out of 100 (B+, Suggest: BUY). This grade factors in S&P 500 comparison, sector and industry performance, financial growth, key metrics, analyst consensus, and forecasts. Meyka AI’s forecast model projects a yearly price of $16.48 versus the current $11.06, implying an upside of 49.00%. Forecasts are model-based projections and not guarantees.

PATH stock risks and opportunities

Opportunity: Continued enterprise automation adoption and cross-sell of AI features could accelerate revenue growth above current consensus. Risk: High average volume and insider selling — insiders sold 950,048 shares in the last 90 days — raise near-term sentiment pressure. Additional risks include elongated sales cycles and competition from larger cloud AI players.

Final Thoughts

Key takeaways for PATH stock: UiPath trades at $11.06 intraday on 19 Feb 2026 with a market cap near $5.94 billion. Fundamentals show reasonable margins, a trailing EPS of $0.42, and a PE of 26.44, while the balance sheet remains healthy with cash per share $2.59 and current ratio 2.54. Technicals are oversold, with RSI 31.23 and the 50-day at $15.38. Meyka AI’s forecast model projects $16.48 for the year, implying +49.00% from today. Analyst price targets cluster around a consensus $15.77, with highs at $19.00 and lows near $12.00. Investors should weigh the upcoming 11 March 2026 earnings, lower liquidity today, and sector momentum in AI. Meyka AI recommends monitoring estimate revisions and using tight risk controls if trading PATH stock. Meyka AI is mentioned as an AI-powered market analysis platform offering model-based projections. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.